Methods for treating conditions associated with masp-2 dependent complement activation

• 收藏
• 分享

专利权人:

OMEROS CORPORATION;UNIVERSITY OF LEICESTER

发明人:

Dudler, Thomas,Demopulos, Gregory,Schwaeble, Hans-Wilhelm

申请号：

NZ74298716

公开号：

NZ742987A

申请日:

2016.11.09

申请国别(地区):

NZ

年份:

2019

代理人:

摘要：

In one aspect, the invention provides methods of inhibiting the effects of MASP-2-dependent complement activation in a human subject suffering from persistent TMA associated with hematopoietic stem cell transplant. The methods comprise the step of administering, to a subject in need thereof, a dosage of 4mg/kg at least weekly for a period of at least 3 weeks of a MASP-2 inhibitory agent effective to inhibit MASP-2-dependent complement activation.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/